Scienture Holdings, Inc.

US$3.12As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SCNXHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (85.25%)
Div yield —
ROE (53.47%)
Pharmaceutical Retailers
Beta (5Y) 4.30
PE TTM —
TSR TTM (83.89%)
Mkt cap US$5.133M
ROIC (10.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.24
3.61%
(63.74%)
Hold 3|1|7|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
28.78%
24.95%
17.61%
3.44%
Revenue$M
0.446
0.443
0.451
0.461
14.51%
11.25%
11.73%
8.81%
Peers (US$5.133M)
Cap (US$)
PE
5.032M
—
Capital
TTM
5Y
10Y
Leveragex
0.242
(1.085)
(0.919)
EBIT/Intx
0.887
0.141
0.136
Own earn%
8.37
(67.52)
(89.25)
Sh yield%
40.94
37.96
37.99
Owners
Insiders/Inst%
12.93
80.82
Short interest%
1.38
SBC / revenue%
4.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
14–23
$1 testx
—
Incr. ROIC%
6